正常雄激素与高雄激素多囊卵巢综合征女性终生呈现不良代谢特征
这项病例对照研究比较了1550例正常雄激素型(n=686)或高雄激素型(n=842)多囊卵巢综合征(PCOS)女性与447例对照女性在育龄期不同年龄段的代谢特征。结果显示,无论雄激素状态如何,PCOS女性从年轻成年至绝经前均较对照更肥胖(尤其腹型),胰岛素、甘油三酯、低密度脂蛋白、总胆固醇和血压更高,高密度脂蛋白更低,且独立于BMI;代谢综合征患病率较对照高2至5倍,高雄激素型晚期育龄女性最高。作者认为评估PCOS代谢风险时应考虑雄激素状态、腹型肥胖和年龄,以便从成年早期开始个体化管理。
要点
- 正常雄激素和高雄激素PCOS女性从年轻成年至绝经前代谢指标均较对照更差,且独立于BMI。
- PCOS女性代谢综合征患病率较对照高2至5倍,高雄激素型晚期育龄女性最高。
- 评估PCOS代谢风险时,雄激素状态、腹型肥胖和年龄应被纳入考虑。
核心结论
- 评估PCOS女性代谢风险时,应考虑雄激素状态、尤其腹型肥胖和年龄,以便从成年早期开始对该综合征进行个体化管理。
研究设计与样本
- 病例对照研究,纳入1550例PCOS女性(正常雄激素型n=686,高雄激素型n=842)和447例对照女性,按年龄分为<30岁、30-39岁和>39岁三组。
主要发现
- 正常雄激素和高雄激素PCOS女性均较对照更肥胖,尤其腹型肥胖。
- 与对照相比,PCOS女性从年轻成年至绝经前空腹及口服葡萄糖耐量试验中胰岛素、甘油三酯、低密度脂蛋白和总胆固醇水平更高,血压更高,高密度脂蛋白更低,且独立于BMI。
- PCOS女性代谢综合征患病率较对照高2至5倍,取决于年龄和表型,高雄激素型PCOS晚期育龄女性患病率最高。
临床怎么用
- 作者认为,评估PCOS女性代谢风险时应考虑雄激素状态、腹型肥胖和年龄,以便从成年早期开始个体化管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the metabolic profiles of normo- and hyperandrogenic women with polycystic ovary syndrome (PCOS) with those of control women at different ages during reproductive life. DESIGN: Case-control study. SETTING: Not applicable. PATIENT(S): In all, 1,550 women with normoandrogenic (n = 686) or hyperandrogenic (n = 842) PCOS and 447 control women were divided into three age groups: <30, 30-39, and >39 years). INTERVENTIONS(S): None. MAIN OUTCOME MEASURE(S): Body mass index (BMI), waist circumference, blood pressure, glucose, insulin, cholesterol, lipoproteins, triglycerides and high-sensitivity C-reactive protein. RESULT(S): Both normo- and hyperandrogenic women with PCOS were more obese, especially abdominally. They had increased serum levels of insulin (fasting and in oral glucose tolerance tests), triglycerides, low-density lipoprotein, and total cholesterol, higher blood pressure, and lower high-density lipoprotein levels independently from BMI compared with the control population as early as from young adulthood until menopause. The prevalence of metabolic syndrome was two- to fivefold higher in women with PCOS compared with control women, depending on age and phenotype, and the highest prevalence was observed in hyperandrogenic women with PCOS at late reproductive age. CONCLUSION(S): When evaluating metabolic risks in women with PCOS, androgenic status, especially abdominal obesity and age, should be taken into account, which would allow tailored management of the syndrome from early adulthood on.
引用
- Pinola P, Puukka K, Piltonen TT, et al. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life. Fertil Steril. 2017. PMID: 28089571. doi:10.1016/j.fertnstert.2016.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。